Publications by authors named "Jason Foo"

Claim this Profile
A
Author Correction: Systematic literature review and meta-analysis of US-approved LAMA/LABA therapies versus tiotropium in moderate-to-severe COPD.
MeiLan K Han, Riju Ray, Jason Foo, Chaienna Morel, Beth Hahn

NPJ Prim Care Respir Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Longitudinal Study of Caregivers of Community Dwelling Persons with Severe Dementia (PISCES): Study Protocol.
Chetna Malhotra, Padmini Vishwanath, Jing Rong Yong, Truls Østbye, Dennis Seow, Jason Foo

J Alzheimers Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Efficacy of Second- and Subsequent-line Treatments for Metastatic NSCLC: A Fractional Polynomials Network Meta-analysis of Cancer Immunotherapies.
Christian Schulz, David Gandara, Carmen G Berardo, Rachel Rosenthal, Jason Foo

Clin Lung Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing ceftolozane/tazobactam versus piperacillin/tazobactam as empiric therapy for complicated urinary tract infection in Taiwan: A cost-utility model focusing on gram-negative bacteria.
Guan-Jhou Chen, Sung-Ching Pan, Jason Foo, Chaienna Morel, Wei-Ting Chen

J Microbiol Immunol Infect· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost per response for abatacept versus adalimumab in patients with seropositive, erosive early rheumatoid arthritis in the US, Germany, Spain, and Canada.
Jason Foo, Chaienna Morel, Martin Bergman, Christoph Baerwald, José Manuel Rodriguez-Heredia

Rheumatol Int· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-consequence analysis for human recombinant growth hormone (r-hGH) treatment administered via different devices in children with growth hormone deficiency in Italy.
Jason Foo, Mohamad Maghnie, Annamaria Colao, Ioanna Vlachaki, Giorgio Colombo

Clinicoecon Outcomes Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic literature review and meta-analysis of US-approved LAMA/LABA therapies versus tiotropium in moderate-to-severe COPD.
MeiLan K Han, Riju Ray, Jason Foo, Chaienna Morel, Beth Hahn

NPJ Prim Care Respir Med· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of ceftolozane/tazobactam plus metronidazole versus piperacillin/tazobactam as initial empiric therapy for the treatment of complicated intra-abdominal infections based on pathogen distributions drawn from national surveillance data in the United States.
Vimalanand S Prabhu, Joseph S Solomkin, Goran Medic, Jason Foo, Rebekah H Borse

Antimicrob Resist Infect Control· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of ceftolozane/tazobactam plus metronidazole compared with piperacillin/tazobactam as empiric therapy for the treatment of complicated intra-abdominal infections based on the in-vitro surveillance of bacterial isolates in the UK.
Vimalanand Prabhu, Jason Foo, Harblas Ahir, Eric Sarpong, Sanjay Merchant

J Med Econ· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada.
Laure Weijers, Christoph Baerwald, Francesco S Mennini, José M Rodríguez-Heredia, Martin J Bergman, Jason Foo

Rheumatol Int· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries.
Jason Foo, Sarah H Landis, Joe Maskell, Yeon-Mok Oh, Thys van der Molen

PLoS One· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis